Canaccord Genuity reaffirmed their buy rating on shares of Intuitive Surgical (NASDAQ:ISRG) in a research report sent to investors on Friday morning, AnalystRatings.com reports.
Several other equities analysts also recently commented on ISRG. Oppenheimer began coverage on shares of Intuitive Surgical in a report on Wednesday, November 20th. They issued a market perform rating on the stock. BidaskClub downgraded shares of Intuitive Surgical from a buy rating to a hold rating in a report on Saturday, January 18th. ValuEngine raised shares of Intuitive Surgical from a strong sell rating to a sell rating in a report on Tuesday, December 3rd. Morgan Stanley boosted their target price on shares of Intuitive Surgical from $620.00 to $670.00 and gave the stock an overweight rating in a report on Tuesday, December 17th. Finally, UBS Group boosted their target price on shares of Intuitive Surgical from $590.00 to $620.00 and gave the stock a neutral rating in a report on Friday, January 10th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of Buy and a consensus target price of $619.62.
Shares of ISRG stock traded down $25.87 during mid-day trading on Friday, hitting $563.33. The company had a trading volume of 13,286 shares, compared to its average volume of 674,128. Intuitive Surgical has a 52-week low of $455.15 and a 52-week high of $616.56. The stock’s 50 day moving average price is $592.69 and its 200-day moving average price is $548.20. The company has a market capitalization of $68.10 billion, a P/E ratio of 48.74, a P/E/G ratio of 4.40 and a beta of 1.12.
Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, January 23rd. The medical equipment provider reported $3.48 EPS for the quarter, topping the consensus estimate of $3.38 by $0.10. Intuitive Surgical had a net margin of 30.80% and a return on equity of 18.16%. The firm had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter in the previous year, the firm earned $2.96 earnings per share. The company’s quarterly revenue was up 22.1% compared to the same quarter last year. As a group, equities analysts expect that Intuitive Surgical will post 11.35 earnings per share for the current year.
In other Intuitive Surgical news, COO Salvatore Brogna sold 12,368 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $580.81, for a total transaction of $7,183,458.08. Also, SVP Jamie Samath sold 225 shares of the business’s stock in a transaction on Friday, December 6th. The shares were sold at an average price of $584.63, for a total transaction of $131,541.75. Following the transaction, the senior vice president now owns 195 shares in the company, valued at approximately $114,002.85. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 13,798 shares of company stock worth $8,008,670. 1.70% of the stock is owned by insiders.
A number of hedge funds have recently bought and sold shares of ISRG. Citizens Financial Group Inc RI grew its position in shares of Intuitive Surgical by 17.8% during the third quarter. Citizens Financial Group Inc RI now owns 119 shares of the medical equipment provider’s stock worth $65,000 after buying an additional 18 shares in the last quarter. Dubuque Bank & Trust Co. boosted its holdings in Intuitive Surgical by 2.1% in the fourth quarter. Dubuque Bank & Trust Co. now owns 858 shares of the medical equipment provider’s stock valued at $507,000 after purchasing an additional 18 shares in the last quarter. Calamos Wealth Management LLC boosted its holdings in Intuitive Surgical by 2.1% in the fourth quarter. Calamos Wealth Management LLC now owns 884 shares of the medical equipment provider’s stock valued at $523,000 after purchasing an additional 18 shares in the last quarter. Lindbrook Capital LLC lifted its stake in Intuitive Surgical by 3.6% in the fourth quarter. Lindbrook Capital LLC now owns 521 shares of the medical equipment provider’s stock valued at $308,000 after buying an additional 18 shares during the last quarter. Finally, TCI Wealth Advisors Inc. lifted its stake in Intuitive Surgical by 9.2% in the fourth quarter. TCI Wealth Advisors Inc. now owns 225 shares of the medical equipment provider’s stock valued at $133,000 after buying an additional 19 shares during the last quarter. Institutional investors and hedge funds own 85.96% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Recommended Story: Most Volatile Stocks – What Investors Need to Know to Maximize ROI
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.